Trial Profile
An Open-Label, 3-Part, 2-Period Study to Examine the Effect of Omeprazole (Part 1), Famotidine (Part 2), and of an Acidic Beverage (Part 3) on the Single-Dose Pharmacokinetics of Entinostat in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Entinostat (Primary) ; Famotidine; Omeprazole
- Indications Cancer
- Focus Pharmacokinetics
- Sponsors Syndax Pharmaceuticals
- 14 Aug 2018 Status changed from recruiting to completed.
- 30 Jan 2017 Status changed from not yet recruiting to recruiting.
- 12 Oct 2016 New trial record